Gender inequalities in secondary prevention of cardiovascular disease: a scoping review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Gender inequalities in secondary prevention of cardiovascular disease: a scoping review ; volume:23 ; number:1 ; day:23 ; month:7 ; year:2024 ; pages:1-14 ; date:12.2024
International journal for equity in health ; 23, Heft 1 (23.7.2024), 1-14, 12.2024
- Creator
-
López Ferreruela, Irene
Obón Azuara, Blanca
Malo Fumanal, Sara
Rabanaque Hernández, María José
Aguilar-Palacio, Isabel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12939-024-02230-3
- URN
-
urn:nbn:de:101:1-2410272116270.193052065468
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- López Ferreruela, Irene
- Obón Azuara, Blanca
- Malo Fumanal, Sara
- Rabanaque Hernández, María José
- Aguilar-Palacio, Isabel
- SpringerLink (Online service)
Other Objects (12)
Smartphones in the secondary prevention of cardiovascular disease: a systematic review
PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
Cardiovascular disease risk and secondary prevention of cardiovascular disease among patients with low health literacy
Evaluation of cardiovascular diseases risk calculators for CVDs prevention and management: scoping review
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
Prevention of cardiovascular diseases
Current Concepts: Comprehensive “Cardiovascular Health” Rehabilitation—An Integrated Approach to Improve Secondary Prevention and Rehabilitation of Cardiovascular Diseases
Cardiovascular risk prevention in children
Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
Smartphones in the secondary prevention of cardiovascular disease: a systematic review
PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
Cardiovascular disease risk and secondary prevention of cardiovascular disease among patients with low health literacy
Evaluation of cardiovascular diseases risk calculators for CVDs prevention and management: scoping review
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
Prevention of cardiovascular diseases
Current Concepts: Comprehensive “Cardiovascular Health” Rehabilitation—An Integrated Approach to Improve Secondary Prevention and Rehabilitation of Cardiovascular Diseases
Cardiovascular risk prevention in children
Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
Smartphones in the secondary prevention of cardiovascular disease: a systematic review
PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
Cardiovascular disease risk and secondary prevention of cardiovascular disease among patients with low health literacy
Evaluation of cardiovascular diseases risk calculators for CVDs prevention and management: scoping review
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
Prevention of cardiovascular diseases
Current Concepts: Comprehensive “Cardiovascular Health” Rehabilitation—An Integrated Approach to Improve Secondary Prevention and Rehabilitation of Cardiovascular Diseases
Cardiovascular risk prevention in children